RE:Priced inHighteawithIntrepid wrote: It would appear that the good news was priced
in. I assume that as part of fending off the short attack
management shared a bit of forward news to
the analyst hence their 3.50-4.50 1 year out target.
I still feel the markets focus on days of cash burn remaining
and a trial burns money. Great news would have been a partner
to pay the bills. The market is a show me the money place.
Lately ANY news seems to have been priced in. As for the price targets though, I have little doubt those can easily be achieved in one or two days with a news release about a solid partnership with 4050. So much weight on the shoulders of this stock revolves around financing / cash worry. Selling a piece of or all of or regional rights or WHATEVER to 4050 at this stage will REALLY boost the stock. Now, all PL has to do is deliver a deal that is GOOD for shareholders and POP I'd bet we are rewarded.
I'll wager that the converse is true too - if PL sits another year without a deal, this stock will very well be sub $1. I am not buying the story that big pharmas are circling the waters surrounding PLI like sharks begging for a piece of the pie. At this point, there is no evidence anyone is even paying attention. Time to SHOW ME THE MONEY.